# TopQ Cut-off Determination Study For 3D-OCT 1 Maestro and 3D OCT-2000

> **NCT02203981** · — · COMPLETED · sponsor: **Topcon Medical Systems, Inc.** · enrollment: 12 (actual)

## Conditions studied

- Healthy

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02203981
- **Lead sponsor:** Topcon Medical Systems, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01
- **Primary completion:** 2014-07
- **Final completion:** 2014-08
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2022-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02203981

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02203981, "TopQ Cut-off Determination Study For 3D-OCT 1 Maestro and 3D OCT-2000". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02203981. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*